Cargando...
Venetoclax-based Therapies for Acute Myeloid Leukemia
The prognosis of adult acute myeloid leukemia (AML) remains poor, with the long-term survival rate less than 50%. However, the current paradigms of treatment are changing through a better understanding of the disease genetics and pathophysiology. Since 2017, eight new drugs have been approved by the...
Gardado en:
| Publicado en: | Best Pract Res Clin Haematol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6581210/ https://ncbi.nlm.nih.gov/pubmed/31203996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2019.05.008 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|